Also a nice snippet about funding capacity. Estimated $16m funding capacity remains from the $24m available at listing.
- Forums
- ASX - By Stock
- HLA
- Cannacord updated research - target price $1.45
Cannacord updated research - target price $1.45, page-5
Featured News
Add HLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online